Clinical Trials Browser

Phase 2 × INDUSTRY × Receptors, Vascular Endothelial Growth Factor × Clear all

NCT00076011 2012-06-26

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Phase 2 Completed

52 enrolled 9 charts

Kidney Neoplasms